Document Classification

Section Type: RESULTS

Text: At the 5-year time point, there were no significant differences in any clinical metric including ischemia-driven target lesion revascularization (TLR ; ZoMaxx 10. 6 % vs. Taxus 7. 1 % ; P = 0. 29), Q-wave myocardial infarction (ZoMaxx 1. 5 % vs. Taxus 1. 0 % ; P = 0. 99), definite/probable stent thrombosis (ZoMaxx 1. 5 % vs. Taxus 3. 0 % ; P = 0. 34), and cardiac death (ZoMaxx 3. 0 % vs. Taxus 1. 0 % ; P = 0. 28).